Here, we described novel markers—S100A8, S100A9, and CD147—which in combination with our recent data on CD15 (16), point to a prominent role of the Calprotectin-CD147-neutrophil axis in the progression of penile cancer that may have additional implications for immunotherapeutic approaches, requiring neutrophils for their efficacy. The gene discussed is FUT4; the disease is penile cancer.